iBio

IBIO · NYSE American

$0.821+$0.0609 (+8.01%)TodayMarket closed ·
Prev close $0.7601

Who owns IBIO

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 49.1% of IBIO’s shares.

  • Affinity Asset Advisors LLC8.1%
  • Cormorant Asset Management, LP7.2%
  • SilverArc Capital Management, LLC7.1%
  • Vestal Point Capital, LP5.2%
  • Next 6 largest institutions21.5%
  • All other shareholders50.9%
Top institutional holders of IBIO
HolderShares% of shares
Affinity Asset Advisors LLC4.01M8.07%
Cormorant Asset Management, LP3.57M7.19%
SilverArc Capital Management, LLC3.52M7.09%
Vestal Point Capital, LP2.60M5.23%
Vanguard Capital Management, LLC2.10M4.22%
Frazier Life Sciences Management, L.P.1.95M3.93%
Ensign Peak Advisors, Inc.1.83M3.69%
Woodline Partners LP1.78M3.58%
Millennium Management LLC1.65M3.32%
Citadel Advisors LLC1.38M2.79%

Largest mutual fund holders

Top mutual fund holders of IBIO
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.47M2.95%
Vanguard Extended Market Index Fund582.07K1.17%
Fidelity Extended Market Index Fund257.76K0.52%
iShares Micro-Cap ETF105.20K0.21%
Fidelity Series Total Market Index Fund75.30K0.15%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of IBIO in the last 6 months.

Latest IBIO insider transactions
InsiderTypeSharesValue
Kropotova AlexandraAward38.00K—
Parada Antonio Bernardino GuimaraesAward38.00K—
Sender GaryAward38.00K—
Stoner ElizabethAward38.00K—
Clark William DAward38.00K—
Arkowitz DavidAward38.00K—
Carr MollyAward430.00K—
Stoner ElizabethAward60.00K—

Short interest

Settled Sep 30, 2026

Shares short
4.20M
Days to cover
6.17
% of shares outstanding
8.46%
Average daily volume
681.57K
Change since last report
−14.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.